169504-70-5

Basic information

• Product Name: Carbamic acid, [2,3-dihydro-5-(1-methylethyl)-2-oxo-1H-1,4-benzodiazepin-3-yl]-, phenylmethyl ester
• CAS NO: 169504-70-5
• Molecular Formula: C20H21N3O3
• Molecular Weight: 351.405
• Mol File: 169504-70-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [2,3-dihydro-5-(1-methylethyl)-2-oxo-1H-1,4-benzodiazepin-3-yl]-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [2,3-dihydro-5-(1-methylethyl)-2-oxo-1H-1,4-benzodiazepin-3-yl]-, phenylmethyl ester(169504-70-5)
• EPA Substance Registry System: Carbamic acid, [2,3-dihydro-5-(1-methylethyl)-2-oxo-1H-1,4-benzodiazepin-3-yl]-, phenylmethyl ester(169504-70-5)

Safety Data

• Hazardous Substances Data: 169504-70-5(Hazardous Substances Data)

Upstream product

• 79-37-8 oxalyl dichloride 
• 2034-40-4 1-(2-aminophenyl)-1-butanone 
• 124676-19-3 2-(benzotriazol-1-yl)-N-(benzyloxycarbonyl)glycine 
• 27309-55-3 1-(2-aminophenyl)-2-methyl-1-propanone 

Downstream Products

• 253135-57-8 3-(benzyloxycarbonyl)-amino-2,3-dihydro-5-isopropyl-1-methyl-1H-1,4-benzodiazepin-2-one 

Relevant articles and documents

Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.